Pharmacokinetics of intravenous oxycodone hydrochloride in perioperative patients with liver cancer
-
By
-
Shuwei Shi
-
Ying Zheng
-
Yong Wang
-
Shengchao Li
-
Rui Feng
-
Luya Li
-
May 28, 2026
-
Clinical Scorecard: Intravenous Oxycodone Hydrochloride Pharmacokinetics in Perioperative Patients Diagnosed with Liver Cancer
At a Glance
| Category | Detail |
|---|
| Condition | |
| Key Mechanisms | |
| Target Population | Perioperative liver cancer patients with normal liver function, considering physiological changes. |
| Care Setting | |
Key Highlights
- Remove unsupported claim regarding individualized analgesic strategies.
Guideline-Based Recommendations
Diagnosis
Management
- Revise to reflect only what is explicitly stated in the source.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Perioperative liver cancer patients with normal liver function.
Pharmacokinetics of oxycodone significantly differ from healthy individuals, necessitating tailored dosing.
Clinical Best Practices
- Include only practices directly supported by the source.
Related Resources & Content
